MIAMI, FL – June 20, 2025 – Ibogaine by David Dardashti, a pioneering leader in ibogaine-assisted therapy and led by visionary David Dardashti, today announced a groundbreaking collaboration with a Psychedelic University. This strategic partnership aims to establish robust internship opportunities for students passionate about contributing to the rapidly evolving psychedelic field, with initial networking prospects ...
Yet, through the practice of meditation and the guidance of sacred plant ceremonies–especially with Iboga–he has emerged with profound insights …
DENVER, CO – June 19, 2025 – Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment ...
Ibogaine is the psychedelic compound derived from the iboga shrub, which is native to central Africa. Although people in other countries have been …
A new clinical program will use ibogaine, a naturally occurring psychedelic, to treat neurodegenerative conditions including Parkinson’s disease.
Ambio Life Sciences, which hosts other ibogaine programming and participates in scientific research about the drug, soft-launched the program in February. It is the first of its kind in the world, according to the company. People with Parkinson’s,